Breaking
Top Investing Channel
Archive

March 31, 2025

Browsing

S&P 500 Dives After Failed Test of Price Resistance; Bears Are in Control

The key resistance level I’ve been watching on the S&P 500 hasn’t wavered. It’s 5782. The bulls had a real chance this past week to clear this important hurdle and they failed. Badly. If this was a heavyweight fight, the ref would have called it after the first round. It simply wasn’t close. Resistance failed, rotation turned bearish, volatility again expanded, and the bears are celebrating another short-term victory.

Check out this S&P 500 chart:

I’ve written about this to EarningsBeats.com members. I posted this exact chart in my StockCharts.com article a few days ago. I’ve discussed it on my YouTube shows. 5782 is THE key short-term price resistance and you can see above that the S&P 500 literally did an “about face” as soon as it touched this resistance. Sellers were lined up. Now that we’ve failed at 5782, it only makes this resistance level that much more important on any future rallies.

The serious technical damage occurred over the past 3 days as consumer discretionary stocks have been absolutely TROUNCED, while consumer staples hangs near its recent highs. If you recall, it was this HUGE disparity in consumer stocks on February 21st that triggered the massive selling episode. Now here we are again with consumer staples stocks (XLP) outperforming discretionary (XLY) by a mile. Check out this chart:

Doesn’t the action in consumer stocks the past 3 days exactly mirror the action we saw in the 2nd half of February and into the first week of March? Folks, this isn’t good.

This is just the tip of the iceberg.

Bear Market Ahead?

The S&P 500, from its recent all-time high to its subsequent low, fell 10.4%, which marks correction territory. The rally we saw off the March 13th low was likely due to oversold conditions, along with March options expiration. On Tuesday, March 18th, we discussed with our EB.com members that odds favored a short-term rally, based on max pain and we laid out key resistance from 5670 to 5782, with the 20-day EMA falling in the middle of this price range. Once we failed at 5782, it was very important to gauge the nature of any new selloff. That’s what I’ve been evaluating this week and it’s not pretty. As you can see in the chart above, money has once again started rotating into the XLP and out of the XLY. This is one of the most important intermarket relationships and it’s screaming BEARISH ACTION AHEAD!

It’s only one signal, however. I announced a few days ago that we’d be hosting a FREE webinar on Saturday morning, March 29th, at 10:00am ET. I plan to discuss several signals that are pointing to exactly what we saw on Friday – more selling. To get a better handle on current market conditions and where we’re heading, I’d encourage you to join me Saturday morning by REGISTERING HERE. If you can’t make the live webinar, we’ll still send out the recorded video to all who register, so ACT NOW!

And here’s a little secret. Shhhhhhh! Market makers are playing some serious games manipulating some of the biggest stocks. I’ll talk a bit about how we can take advantage of that Saturday morning. Hope to see you there!

Happy trading!

Tom

David Morgan: Silver Squeeze 2.0 — Will Price Run on March 31?

Will a second iteration of the silver squeeze move the metal’s price on Monday (March 31)?

David Morgan, publisher of the Morgan Report, shares his thoughts on what’s to come.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Silver Crown Royalties Announces Closing of Second Tranche of its Non-Brokered Private Placement

(TheNewswire)

TORONTO, ON TheNewswire – March 31, 2025 Silver Crown Royalties Inc. ( Cboe: SCRI, OTCQX: SLCRF, BF: QS0 ) (‘ Silver Crown ‘, ‘ SCRi ‘, or the ‘ Company ‘) is pleased to provide an update on its non-brokered offering of units (‘Units ‘) that was previously announced on February 6, 2025 (the ‘ Offering ‘).

In connection with the Offering, the Company has successfully closed the second tranche (‘ Second Tranche ‘) and issued 75,310 Units at a price of C$6.50 per Unit, for gross proceeds of approximately C$489,515. Each Unit consists of one common share (‘ Common Share ‘) and one Common Share purchase warrant (‘ Warrant ‘), with each Warrant exercisable to acquire one additional Common Share at an exercise price of C$13.00 for a period of three years from the closing date.  The total units issued under this Offering total 142,848 for cumulative gross proceeds of C$928,512.

The proceeds from the Second Tranche will be used to partially fund the second tranche of the Company’s silver royalty acquisition on the Igor 4 project in Peru, as well as general and administrative expenses. All securities issued are subject to a statutory hold period of four months plus one day from the date of issuance, in accordance with applicable securities legislation. The closing was subject to customary conditions, including the approval of Cboe Canada Inc.

ABOUT Silver Crown Royalties INC.

Founded by industry veterans, Silver Crown Royalties ( Cboe: SCRI | OTCQX: SLCRF | BF: QS0 ) is a publicly traded, silver royalty company. Silver Crown (SCRi) currently has four silver royalties of which three are revenue-generating. Its business model presents investors with precious metals exposure that allows for a natural hedge against currency devaluation while minimizing the negative impact of cost inflation associated with production. SCRi endeavors to minimize the economic impact on mining projects while maximizing returns for shareholders. For further information, please contact:

Silver Crown Royalties Inc.

Peter Bures, Chairman and CEO

Telephone: (416) 481-1744

Email: pbures@silvercrownroyalties.com

FORWARD-LOOKING STATEMENTS

This release contains certain ‘forward looking statements’ and certain ‘forward-looking information’ as defined under applicable Canadian and U.S. securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as ‘may’, ‘will’, ‘should’, ‘expect’, ‘intend’, ‘estimate’, ‘anticipate’, ‘believe’, ‘continue’, ‘plans’ or similar terminology. The forward-looking information contained herein is provided for the purpose of assisting readers in understanding management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. Forward-looking statements and information include, but are not limited to, the proceeds from the Second Tranche will be used to partially fund the second tranche of the Company’s silver royalty acquisition on the Igor 4 project in Peru, as well as general and administrative expenses. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual actions, events or results to be materially different from those expressed or implied by such forward-looking information, including but not limited to: the impact of general business and economic conditions; the absence of control over mining operations from which SCRi will purchase gold and other metals or from which it will receive royalty payments and risks related to those mining operations, including risks related to international operations, government and environmental regulation, delays in mine construction and operations, actual results of mining and current exploration activities, conclusions of economic evaluations and changes in project parameters as plans continue to be refined; accidents, equipment breakdowns, title matters, labor disputes or other unanticipated difficulties or interruptions in operations; SCRi’s ability to enter into definitive agreements and close proposed royalty transactions; the inherent uncertainties related to the valuations ascribed by SCRi to its royalty interests; problems inherent to the marketability of gold and other metals; the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses; industry conditions, including fluctuations in the price of the primary commodities mined at such operations, fluctuations in foreign exchange rates and fluctuations in interest rates; government entities interpreting existing tax legislation or enacting new tax legislation in a way which adversely affects SCRi; stock market volatility; regulatory restrictions; liability, competition, the potential impact of epidemics, pandemics or other public health crises on SCRi’s business, operations and financial condition, loss of key employees. SCRi has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. SCRi undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents management’s best judgment based on information currently available.

This document does not constitute an offer to sell, or a solicitation of an offer to buy, securities of the Company in Canada, the United States or any other jurisdiction. Any such offer to sell or solicitation of an offer to buy the securities described herein will be made only pursuant to subscription documentation between the Company and prospective purchasers. Any such offering will be made in reliance upon exemptions from the prospectus and registration requirements under applicable securities laws, pursuant to a subscription agreement to be entered into by the Company and prospective investors. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.

CBOE CANADA DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.

Copyright (c) 2025 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com

Stock Market News UK Update: FTSE 100 & 250 Rise

Stock Market News: UK Forecast and Technical Analysis

Today, the UK stock market saw the FTSE 250 increase by 195 points (0.9%) to 21,628, nearly matching the 1.2% increase in the FTSE 100, driven largely by gains in mining stocks. This positive momentum is creating a bullish sentiment in the market.

The two London indices are leading the European market this morning. The DAX is up 0.7% in Germany, followed by the FTSE MIB in Italy, the CAC 40 in France, and the IBEX 35 in Spain, all of which are up 0.4%, reinforcing the optimistic outlook across Europe.

The gain for the Euro Stoxx 600 is just under 1%. Risers include Just Eat Takeaway, rising 17%; TeamViewer, the software company and owner of Kenco, JD Peet.

Among the higher risers, Wickes Group PLC, one of the UK’s listed companies, has seen a 3.3% increase in revenue despite facing difficulties retaining customers for its custom kitchen, home office installation, and bathroom services.

In the first half, this segment’s revenues were destroyed by 17%, offsetting the 1% growth in revenue in its core retail offering.

GSK Shares Decline

GSK PLC, the drugmaker listed on the FTSE 100, raised its annual earnings and sales forecasts due to strong second-quarter performance from HIV and cancer treatments, but the stock is currently down 2.5%.

Core EPS profits are now expected to increase by 10-12% in 2024, up from the previous guidance of 8-10%. Meanwhile, the overall profits are expected to increase by 7-9%, compared to the earlier estimate of 5-7%.

Nonetheless, there were some omissions in the data: vaccination profit fell 9% short of expectations as shingles treatment Shingrix was a 20% disappointment as US sales plummeted 36%.

This is due to decreased demand and inventory reductions. However, it is important to note that international sales make up about 64% of total revenue.

General medicine, oncology, and HIV all performed better than anticipated.

GSK/GBX 5-Day Chart

Growth Expectation For FTSE 250

In the last five years, Greggs’ shares have increased by 40%, outpacing the FTSE 250 London stock. The company’s first-half (H1) results have given them an additional 5% boost.

The most recent data shows a 16% increase in profit before taxes and a 14% increase in sales.

However, despite these gains, projections indicate a minor decline in Greggs’ EPS for the full year 2024. However, the company’s first-half revenue increased by only 15%.

It is a basic diluted estimate that does not account for anomalies. However, it raises the possibility that projections are simply exaggerating the situation.

Thanks to these expenditures and a well-defined expansion plan, Greggs has produced substantial returns for its owners.

For the 2023 fiscal year, Greggs reported record yearly sales of £1.8 billion and a profit before taxes of £188.3 million.

The company also disclosed a significant capital investment program aimed at enhancing its manufacturing capacity and expanding its capacity to accommodate approximately 3,500 stores throughout the United Kingdom.

UK Stock Market Today: FTSE Stock Surge

Among the top risers in the FTSE, Antofagasta PLC and Rio Tinto have shown significant gains. Antofagasta PLC saw notable gains despite no specific news being released. Rio Tinto’s positive results, which included a 1.8% increase in first-half profit, contributed to a 1% rise in its shares and may have influenced the broader market.

More significantly, there are rumours that the Anglo-Australian miner Antofagasta is eyeing a major opportunity in the copper industry, further boosting investor confidence.

The Footsie has continued to rise, hitting a two-month peak of nearly 8,374 following a 1.2% increase. This is the highest value for the London standard since May 22nd, topping 8,368.

HSBC Makes a £3 Billion Buyback

Following a largely flat first half of the year, HSBC Holdings PLC announced an additional interim dividend and a £3 billion share buyback.

For the first half of 2024, the £0.10 per share dividend will equate to 20 cents, unchanged from the previous year. The share buyback is anticipated to be finished in three months.

The bank, with a focus on Asia, reported a first-half pre-tax profit of $21.6 billion, which was marginally lower than the same period last year, even though revenue increased 1% to $37.3 billion and certain “strategic transactions” had a net positive revenue impact of $0.2 billion.

The second quarter’s $16.5 billion in revenues exceeded analysts’ expectations, and the quarter’s $8.9 billion profit before taxes was significantly more than the $7.8 billion they had predicted.

Despite being lower than the 1.53% consensus estimate, the net interest margin improved from 1.7% to 1.62% a year ago due to an increase in the finance cost of average profit liabilities. These developments are significant for the stock market news UK, as they may influence investor sentiment and market trends.

FTSE 250 Share Price

  • Value: 21,572.34
  • Net Variation: 139.83
  • High/Low: 21,649.47 / 21,430.07
  • Previously closed price: 21,432.51
  • 52WK range: 16,783.09 – 21,432.51
  • Launch date: October 12th 1992
  • Constituents number: 250
  • Net MCap: 324,478
  • Dividend Yield: 3.35%
  • Average: 1,298
  • Largest: 4,059
  • Smallest: 81
  • Median: 1,085

FTSE 100 Share Price

  • Value: 8,390.33
  • Previous Close: 8,292.35
  • Open Price: 8,292.35
  • Day low: 8,235.55
  • Day High: 8,297.92
  • 52-week low: 7,215.76
  • 52-week high: 8,474.41

In summary, today’s gains on the stock market news UK are remarkable, as the FTSE 100 and FTSE 250 indices both saw an increase. Mining stocks, especially in the FTSE 100, have primarily driven these gains. Major indices have also increased throughout Europe, indicating an optimistic trend in the market.

While GSK continues to face difficulties even after increasing its earnings projections, Greggs has shown remarkable growth in both its stock price as well as profitability. Despite a little fluctuation in its profit margins, HSBC’s announcement of a significant share buyback and dividend demonstrates the strength of its financial position.

The post Stock Market News UK Update: FTSE 100 & 250 Rise appeared first on FinanceBrokerage.

Stock Market News UK Update: FTSE 100 & 250 Rise

Stock Market News: UK Forecast and Technical Analysis

Today, the UK stock market saw the FTSE 250 increase by 195 points (0.9%) to 21,628, nearly matching the 1.2% increase in the FTSE 100, driven largely by gains in mining stocks. This positive momentum is creating a bullish sentiment in the market.

The two London indices are leading the European market this morning. The DAX is up 0.7% in Germany, followed by the FTSE MIB in Italy, the CAC 40 in France, and the IBEX 35 in Spain, all of which are up 0.4%, reinforcing the optimistic outlook across Europe.

The gain for the Euro Stoxx 600 is just under 1%. Risers include Just Eat Takeaway, rising 17%; TeamViewer, the software company and owner of Kenco, JD Peet.

Among the higher risers, Wickes Group PLC, one of the UK’s listed companies, has seen a 3.3% increase in revenue despite facing difficulties retaining customers for its custom kitchen, home office installation, and bathroom services.

In the first half, this segment’s revenues were destroyed by 17%, offsetting the 1% growth in revenue in its core retail offering.

GSK Shares Decline

GSK PLC, the drugmaker listed on the FTSE 100, raised its annual earnings and sales forecasts due to strong second-quarter performance from HIV and cancer treatments, but the stock is currently down 2.5%.

Core EPS profits are now expected to increase by 10-12% in 2024, up from the previous guidance of 8-10%. Meanwhile, the overall profits are expected to increase by 7-9%, compared to the earlier estimate of 5-7%.

Nonetheless, there were some omissions in the data: vaccination profit fell 9% short of expectations as shingles treatment Shingrix was a 20% disappointment as US sales plummeted 36%.

This is due to decreased demand and inventory reductions. However, it is important to note that international sales make up about 64% of total revenue.

General medicine, oncology, and HIV all performed better than anticipated.

GSK/GBX 5-Day Chart

Growth Expectation For FTSE 250

In the last five years, Greggs’ shares have increased by 40%, outpacing the FTSE 250 London stock. The company’s first-half (H1) results have given them an additional 5% boost.

The most recent data shows a 16% increase in profit before taxes and a 14% increase in sales.

However, despite these gains, projections indicate a minor decline in Greggs’ EPS for the full year 2024. However, the company’s first-half revenue increased by only 15%.

It is a basic diluted estimate that does not account for anomalies. However, it raises the possibility that projections are simply exaggerating the situation.

Thanks to these expenditures and a well-defined expansion plan, Greggs has produced substantial returns for its owners.

For the 2023 fiscal year, Greggs reported record yearly sales of £1.8 billion and a profit before taxes of £188.3 million.

The company also disclosed a significant capital investment program aimed at enhancing its manufacturing capacity and expanding its capacity to accommodate approximately 3,500 stores throughout the United Kingdom.

UK Stock Market Today: FTSE Stock Surge

Among the top risers in the FTSE, Antofagasta PLC and Rio Tinto have shown significant gains. Antofagasta PLC saw notable gains despite no specific news being released. Rio Tinto’s positive results, which included a 1.8% increase in first-half profit, contributed to a 1% rise in its shares and may have influenced the broader market.

More significantly, there are rumours that the Anglo-Australian miner Antofagasta is eyeing a major opportunity in the copper industry, further boosting investor confidence.

The Footsie has continued to rise, hitting a two-month peak of nearly 8,374 following a 1.2% increase. This is the highest value for the London standard since May 22nd, topping 8,368.

HSBC Makes a £3 Billion Buyback

Following a largely flat first half of the year, HSBC Holdings PLC announced an additional interim dividend and a £3 billion share buyback.

For the first half of 2024, the £0.10 per share dividend will equate to 20 cents, unchanged from the previous year. The share buyback is anticipated to be finished in three months.

The bank, with a focus on Asia, reported a first-half pre-tax profit of $21.6 billion, which was marginally lower than the same period last year, even though revenue increased 1% to $37.3 billion and certain “strategic transactions” had a net positive revenue impact of $0.2 billion.

The second quarter’s $16.5 billion in revenues exceeded analysts’ expectations, and the quarter’s $8.9 billion profit before taxes was significantly more than the $7.8 billion they had predicted.

Despite being lower than the 1.53% consensus estimate, the net interest margin improved from 1.7% to 1.62% a year ago due to an increase in the finance cost of average profit liabilities. These developments are significant for the stock market news UK, as they may influence investor sentiment and market trends.

FTSE 250 Share Price

  • Value: 21,572.34
  • Net Variation: 139.83
  • High/Low: 21,649.47 / 21,430.07
  • Previously closed price: 21,432.51
  • 52WK range: 16,783.09 – 21,432.51
  • Launch date: October 12th 1992
  • Constituents number: 250
  • Net MCap: 324,478
  • Dividend Yield: 3.35%
  • Average: 1,298
  • Largest: 4,059
  • Smallest: 81
  • Median: 1,085

FTSE 100 Share Price

  • Value: 8,390.33
  • Previous Close: 8,292.35
  • Open Price: 8,292.35
  • Day low: 8,235.55
  • Day High: 8,297.92
  • 52-week low: 7,215.76
  • 52-week high: 8,474.41

In summary, today’s gains on the stock market news UK are remarkable, as the FTSE 100 and FTSE 250 indices both saw an increase. Mining stocks, especially in the FTSE 100, have primarily driven these gains. Major indices have also increased throughout Europe, indicating an optimistic trend in the market.

While GSK continues to face difficulties even after increasing its earnings projections, Greggs has shown remarkable growth in both its stock price as well as profitability. Despite a little fluctuation in its profit margins, HSBC’s announcement of a significant share buyback and dividend demonstrates the strength of its financial position.

The post Stock Market News UK Update: FTSE 100 & 250 Rise appeared first on FinanceBrokerage.